Back to Agenda
Reflection on the Escalating Growth of the Medical Science Liaison Role
Session Chair(s)
J. Lynn Bass, PharmD, RPh
Senior Director, Medical Science Liaisons
BridgeBio, United States
The pharmaceutical industry is composed of diverse constituents who, as a whole, result in a unique, overall industry. Since the inaugural team of Medical Science Liaisons (MSL) was deployed, the role and function of the individual MSL has advanced and pivoted in numerous directions. In addition, structuring and building MSL teams has become a challenge and is dependent on the needs of the unique components. Diverse skill sets and qualifications from both the management and individual contributor roles are required. This session will review the development of the MSL role in the traditional pharmaceutical and biotech industries, and contrast and examine the unique qualities of MSLs deployed in the Medical Device and Diagnostics sector of the industry today. Guest panelists representing traditional pharmaceuticals and Biotech and Medical Diagnostics industries will share unique and common characteristics of each of these sectors.
Speaker(s)
Opening Remarks - MSL Track
Ramineh Zoka, PharmD, MS
Janssen Services, LLC, United States
Senior Director, Medical Science Liaison, Medical Affairs
Faculty
Drew Scheifele, PhD
Biogen, Sinagore, China
Head of Medical, Asia Pacific Region
Faculty
Vickee Beissel Altman, MEd, RN
Roche Diagnostics, United States
MSA National MSL Manager
Have an account?